Single-Arm Studies Can Have Adaptive Designs, Industry Tells FDA

FDA's recent draft guidance on adaptive device trial designs is a good step, but it should be more inclusive of single-arm studies and not just randomized trials, AdvaMed says.

Adaptive clinical trial designs can be employed for single-arm as well as randomized studies, device companies tell FDA in response to a recent draft guidance

More from Archive

More from Medtech Insight